Optimistic Future for Eli Lilly: Potential Approval and Impact of Mounjaro in Obstructive Sleep Apnea Treatment Landscape

Leerink Partners analyst Mike Kratky has maintained their bullish stance on LLY stock, giving a Buy rating yesterday. Mike Kratky’s Buy r...

Related Keywords

Mike Kratky , Eli Lilly Co , Argus Research , Leerink Partners , Eli Lilly , Apnea Hypopnea Index , Tipranks Premium ,